Belpointe Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-35
Closed -$813 2316
2023
Q1
$813 Buy
+35
New +$813 ﹤0.01% 3508